NexImmune (NASDAQ:NEXI – Get Free Report) and Spyre Therapeutics (NASDAQ:SYRE – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk. Insider and Institutional Ownership 9.9% of NexImmune shares […]
NexImmune, Inc. (NASDAQ:NEXI – Get Free Report) was the recipient of a significant growth in short interest in the month of September. As of September 30th, there was short interest totalling 134,900 shares, a growth of 21.3% from the September 15th total of 111,200 shares. Based on an average daily volume of 83,300 shares, the […]
NexImmune, Inc. (NASDAQ:NEXI) Sees Large Decrease in Short Interest theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
NexImmune, Inc. (NASDAQ:NEXI) Short Interest Update theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
NexImmune, Inc. (NASDAQ:NEXI – Get Free Report) was the recipient of a significant drop in short interest during the month of July. As of July 15th, there was short interest totalling 286,700 shares, a drop of 19.3% from the June 30th total of 355,400 shares. Approximately 1.8% of the company’s shares are short sold. Based […]